Caprock Group, Inc. Natera, Inc. Transaction History

Caprock Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$30.32 - $91.33 $73,374 - $221,018	-2,420 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$86.26 - $119.0 $9,057 - $12,495	-105 Reduced 4.16%	2,420 $226,000
Q3 2021 Oct 07, 2021	BUY	$100.17 - $126.36 $75,828 - $95,654	757 Added 42.82%	2,525 $281,000
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $152,136 - $211,664	1,768 New	1,768 $201,000

439

117M

254K

263K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.